Business Context and Reporting Period
This filing summarizes the proceedings of Philip Morris International Inc.'s (PMI) 2015 Annual Meeting of Shareholders held on May 6, 2015. The company, a leading international tobacco firm with operations in over 180 markets, highlighted its momentum in traditional cigarette sales and the launch of its first Reduced-Risk Product, iQOS.
Key Financial Metrics and Guidance
- 2015 EPS Forecast: Reported diluted earnings per share are projected to be between $4.32 and $4.42.
- 2014 EPS Comparison: 2014 reported diluted EPS was $4.76. Adjusted 2014 diluted EPS was $5.02 (excluding a $0.26 charge for asset impairment and exit costs).
- Currency Impact: An unfavorable currency impact of approximately $1.15 per share is expected for the full year 2015.
- Organic Growth: Excluding currency effects, reported diluted EPS is projected to increase by 9% to 11% versus the adjusted 2014 diluted EPS of $5.02.
- Free Cash Flow: Forecast to be broadly in line with 2014 levels despite currency headwinds.
- Share Repurchases: The 2015 forecast does not include any share repurchases.
Material Changes and Strategic Focus
Management noted that 2014 was an investment year focused on resolving market challenges, optimizing manufacturing, and launching the Marlboro 2.0 Architecture. The primary material change for 2015 is the incremental spending required for the deployment of iQOS. This spending is skewed toward the second half of the year to support national expansion in Japan and Italy, as well as pilot or national launches in additional markets. The company reported that iQOS is performing above expectations.
Outlook, Risks, and Contingencies
Management reaffirmed its commitment to returning cash to shareholders through dividends while investing in long-term growth. The outlook excludes the impact of future acquisitions, unanticipated asset impairments, or unusual events. Significant risks identified include:
- Fluctuations in currency exchange rates and devaluations.
- Increases in cigarette-related taxes and discriminatory excise tax structures.
- Regulatory restrictions and litigation related to tobacco use.
- Success in producing and commercializing products with reduced risk profiles.
- Counterfeiting, contraband, and cross-border purchases.
Investor Verification Checklist
- Verify the actual second-half spending trajectory for iQOS expansion in Japan, Italy, and new markets.
- Monitor currency exchange rate fluctuations to assess the $1.15 per share negative impact on EPS.
- Confirm the timeline for any potential share repurchase programs not included in the current forecast.
- Review regulatory approvals for Reduced-Risk Product claims in key markets.
- Track the final voting results for the election of directors and executive compensation, to be filed in a subsequent Form 8-K.